Relative Bioavailability Study of a Fixed-dose Combination Dolutegravir/Abacavir/Lamivudine Dispersible Tablet

Clinical trial NCT02893488 · COMPLETED

Trial details

NCT number: NCT02893488
Sponsor: ViiV Healthcare
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Infection, Human Immunodeficiency Virus

Start date: 2016-09-01
Primary completion: 2016-11-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.